Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study
Dominique van Mil(University Medical Center Groningen), Ron T. Gansevoort(University Medical Center Groningen), Hiddo J.L. Heerspink(University Medical Center Groningen), Marc Thelen(Radboud University Nijmegen), Marc H. Hemmelder(Nefrovisie), Ronald W. van Etten(Amphia Ziekenhuis), A Dorgelo(Nierstichting), Birgitte Evers-Roeten, Hanne de Vries(Jeroen Bosch Ziekenhuis), Lyanne M. Kieneker(University Medical Center Groningen)
Cited by 7
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k